These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [In depth analysis of 2 studies of prostate cancer screening--what makes sense?]. Recker F Praxis (Bern 1994); 2010 Feb; 99(3):183-5. PubMed ID: 20127638 [No Abstract] [Full Text] [Related]
5. Efficacy vs effectiveness in prostate-specific antigen screening. Albertsen PC J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583 [No Abstract] [Full Text] [Related]
6. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? Barry MJ; Mulley AJ J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451 [No Abstract] [Full Text] [Related]
7. Prostate cancer in the serum prostate-specific antigen era. Humphrey PA Mayo Clin Proc; 1998 May; 73(5):489-90. PubMed ID: 9581595 [No Abstract] [Full Text] [Related]
8. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years? Hoeltl W; Müller MM; Lunglmayr G J Urol; 2005 Jun; 173(6):2205; author reply 2205-6. PubMed ID: 15879895 [No Abstract] [Full Text] [Related]
9. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America. Colli JL; Amling CL Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening; is this a teachable moment? Brawley OW J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970 [No Abstract] [Full Text] [Related]
11. Why prostate cancer screening is necessary. Witte MN; Lindaman BD; Rosinsky DE S D Med; 2015; Spec No():88-91. PubMed ID: 25985616 [No Abstract] [Full Text] [Related]
14. [Prostate cancer screening: no proof of the benefit]. Laplanche A; Hill C Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979 [No Abstract] [Full Text] [Related]
16. Impact of screening on incidence and mortality of prostate cancer in the United States. Potosky AL; Feuer EJ; Levin DL Epidemiol Rev; 2001; 23(1):181-6. PubMed ID: 11588846 [TBL] [Abstract][Full Text] [Related]
17. [Impact of PSA screening on mortality. PLCO project team (prostate, lung, colorectal, ovarian cancer screening trial)]. Heidenreich A; Nitschmann S Internist (Berl); 2010 Feb; 51(2):219-20. PubMed ID: 20107755 [No Abstract] [Full Text] [Related]
18. Celebrating the death of PSA screening? Gomella LG Can J Urol; 2011 Dec; 18(6):5987. PubMed ID: 22166323 [No Abstract] [Full Text] [Related]
19. Diagnosis of localized, screen-detected, prostate cancer--crisis or opportunity? Yao SL; Lu-Yao GL J Natl Cancer Inst; 2010 Jul; 102(13):919-20. PubMed ID: 20562372 [No Abstract] [Full Text] [Related]